| Year |
Citation |
Score |
| 2023 |
Wheeler CM, Torrez-Martinez NE, Torres-Chavolla E, Parvu V, Andrews JC, DU R, Robertson M, Joste NE, Cuzick J. Comparing the performance of two HPV assays for a new use indication: a real-world evidence-based evaluation in the United States. American Journal of Obstetrics and Gynecology. PMID 37806613 DOI: 10.1016/j.ajog.2023.09.100 |
0.67 |
|
| 2023 |
Cuzick J, Adcock R, Kinney W, Castle PE, Robertson M, McDonald RM, Stoler MH, Du R, Wheeler CM. Impact of HPV testing in Opportunistic Cervical Screening: Support for Primary HPV Screening in the United States. International Journal of Cancer. PMID 36946690 DOI: 10.1002/ijc.34519 |
0.656 |
|
| 2023 |
Velentzis LS, Hawkes D, Caruana M, Brotherton JM, Smith MA, Roeske L, Karim KA, Garland SM, Wrede CD, Tan J, Wheeler C, Castle PE, Saville M, Canfell K. Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening. Tumour Virus Research. 200255. PMID 36736490 DOI: 10.1016/j.tvr.2023.200255 |
0.616 |
|
| 2023 |
Del Vecchio NJ, Beaber EF, Garcia MP, Wheeler CM, Kamineni A, Chao C, Chubak J, Corley DA, Owens CL, Winer RL, Pruitt SL, Raine-Bennett T, Feldman S, Silverberg M. Provider- and Facility-Level Variation in Pre-Cancerous Cervical Biopsy Diagnoses. Journal of Lower Genital Tract Disease. PMID 36728078 DOI: 10.1097/LGT.0000000000000721 |
0.362 |
|
| 2022 |
Chao CR, Chubak J, Beaber EF, Kamineni A, Mao C, Silverberg MJ, Tiro JA, Skinner C, Garcia M, Corley DA, Winer RL, Raine-Bennett T, Feldman S, Wheeler CM. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Medicine. PMID 36106421 DOI: 10.1002/cam4.5226 |
0.514 |
|
| 2022 |
Brown DR, Castellsagué X, Ferris D, Garland SM, Huh W, Steben M, Wheeler CM, Saah A, Luxembourg A, Li S, Velicer C. Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women. Tumour Virus Research. 200236. PMID 35525430 DOI: 10.1016/j.tvr.2022.200236 |
0.576 |
|
| 2022 |
Adcock R, Nedjai B, Lorincz A, Scibior-Bentkowska D, Banwait R, Torrez-Martinez N, Robertson M, Cuzick J, Wheeler CM. DNA methylation testing with S5 for triage of high-risk HPV positive women. International Journal of Cancer. PMID 35477862 DOI: 10.1002/ijc.34050 |
0.611 |
|
| 2021 |
Banila C, Lorincz AT, Scibior-Bentkowska D, Clifford GM, Kumbi B, Beyene D, Wheeler CM, Cuschieri K, Cuzick J, Nedjai B. Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study. International Journal of Cancer. PMID 34562270 DOI: 10.1002/ijc.33815 |
0.45 |
|
| 2021 |
Castle PE, Kinney WK, Chen L, Kim JJ, Jenison S, Rossi G, Kang H, Cuzick J, Wheeler CM. Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation from a Statewide Registry. Journal of the National Cancer Institute. PMID 34463763 DOI: 10.1093/jnci/djab173 |
0.307 |
|
| 2021 |
Perkins RB, Adcock R, Benard V, Cuzick J, Waxman A, Howe J, Melkonian S, Gonzales J, Wiggins C, Wheeler CM. Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations. Preventive Medicine. 106770. PMID 34416221 DOI: 10.1016/j.ypmed.2021.106770 |
0.534 |
|
| 2021 |
Hernández-López R, Hermosillo L, León-Maldonado L, Velázquez-Cruz R, Torres-Ibarra L, Lazcano-Ponce E, Lörincz A, Wheeler CM, Bosch FX, Cuzick J, Rivera-Paredez B, Nedjai B, Salmerón J. Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women. Plos One. 16: e0254946. PMID 34288949 DOI: 10.1371/journal.pone.0254946 |
0.518 |
|
| 2021 |
Cuzick J, Du R, Adcock R, Kinney W, Joste N, McDonald RM, English K, Torres SM, Saslow D, Wheeler CM. Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States. Gynecologic Oncology. PMID 34253387 DOI: 10.1016/j.ygyno.2021.06.029 |
0.654 |
|
| 2020 |
Torres-Ibarra L, Lorincz AT, Wheeler CM, Cuzick J, Hernández-López R, Spiegelman D, León-Maldonado L, Rivera-Paredez B, Méndez-Hernández P, Lazcano-Ponce E, Salmerón J. Adjunctive Testing by Cytology, p16/Ki-67 Dual-Stained Cytology or HPV16/18 E6 Oncoprotein for the Management of HPV16/18 Screen-Positive Women. International Journal of Cancer. PMID 33252834 DOI: 10.1002/ijc.33414 |
0.671 |
|
| 2020 |
Brotherton JML, Wheeler C, Clifford G, Elfstrom M, Saville M, Kaldor J, Machalek DA. Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment. Preventive Medicine. 106293. PMID 33075352 DOI: 10.1016/j.ypmed.2020.106293 |
0.559 |
|
| 2020 |
Landy R, Mathews C, Robertson M, Wiggins CL, McDonald YJ, Goldberg DW, Scarinci IC, Cuzick J, Sasieni PD, Wheeler CM. A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States. Gynecologic Oncology. PMID 32977987 DOI: 10.1016/j.ygyno.2020.08.033 |
0.384 |
|
| 2020 |
Tota JE, Struyf F, Hildesheim A, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, ... Wheeler CM, et al. Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials. The Journal of Infectious Diseases. PMID 32887990 DOI: 10.1093/Infdis/Jiaa561 |
0.684 |
|
| 2019 |
Landy R, Sasieni PD, Mathews C, Wiggins CL, Robertson M, McDonald YJ, Goldberg DW, Scarinci IC, Cuzick J, Wheeler CM. Impact of screening on cervical cancer incidence. A population-based case-control study in the United States. International Journal of Cancer. PMID 31837006 DOI: 10.1002/Ijc.32826 |
0.448 |
|
| 2019 |
Wheeler CM, Struyf F. VIVIANE study of HPV vaccination - Authors' reply. Lancet Infectious Diseases. 19: 1282-1283. PMID 31782389 DOI: 10.1016/S1473-3099(19)30641-3 |
0.668 |
|
| 2019 |
Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico. Jama Network Open. 2: e1915781. PMID 31747033 DOI: 10.1001/jamanetworkopen.2019.15781 |
0.654 |
|
| 2019 |
Castle PE, Adcock R, Cuzick J, Wentzensen N, Torrez-Martinez NE, Torres SM, Stoler MH, Ronnett BM, Joste NE, Darragh TM, Gravitt PE, Schiffman M, Hunt WC, Kinney WK, Wheeler CM, et al. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology. Archives of Pathology & Laboratory Medicine. PMID 31718233 DOI: 10.5858/Arpa.2019-0241-Oa |
0.522 |
|
| 2019 |
Tota JE, Struyf F, Sampson JN, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, Wheeler CM, et al. Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials. Journal of the National Cancer Institute. PMID 31697384 DOI: 10.1093/Jnci/Djz222 |
0.721 |
|
| 2019 |
Adcock R, Cuzick J, Hunt WC, McDonald RM, Wheeler CM. Role of HPV genotype, multiple infections and viral load on the risk of high-grade cervical neoplasia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31488417 DOI: 10.1158/1055-9965.Epi-19-0239 |
0.696 |
|
| 2019 |
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, ... ... Wheeler CM, et al. Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. Journal of the National Cancer Institute. PMID 31292633 DOI: 10.1093/Jnci/Djz137 |
0.343 |
|
| 2019 |
Rosillon D, Baril L, Del Rosario-Raymundo MR, Wheeler CM, Skinner SR, Garland SM, Salmeron J, Lazcano-Ponce E, Vallejos CS, Stoney T, Ter Harmsel B, Lim TYK, Quek SC, Minkina G, McNeil SA, et al. Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies. Cancer Medicine. PMID 31273942 DOI: 10.1002/Cam4.1879 |
0.748 |
|
| 2018 |
Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Doria-Rose VP. Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort. International Journal of Cancer. PMID 30353911 DOI: 10.1002/Ijc.31940 |
0.633 |
|
| 2018 |
Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, ... Wheeler CM, et al. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age. Obstetrics and Gynecology. PMID 29995724 DOI: 10.1097/Aog.0000000000002736 |
0.511 |
|
| 2018 |
Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, et al. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. Ca: a Cancer Journal For Clinicians. PMID 29603147 DOI: 10.3322/Caac.21452 |
0.315 |
|
| 2018 |
Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ. Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Preventive Medicine. 111: 177-179. PMID 29548787 DOI: 10.1016/J.Ypmed.2018.03.011 |
0.339 |
|
| 2017 |
Arrossi S, Temin S, Garland S, Eckert LO, Bhatla N, Castellsagué X, Alkaff SE, Felder T, Hammouda D, Konno R, Lopes G, Mugisha E, Murillo R, Scarinci IC, Stanley M, ... ... Wheeler CM, et al. Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline. Journal of Global Oncology. 3: 611-634. PMID 29094100 DOI: 10.1200/Jgo.2016.008151 |
0.434 |
|
| 2017 |
Cuzick J, Myers O, Lee JH, Shi Y, Gage JC, Hunt WC, Robertson M, Wheeler CM. Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing. Jama Oncology. PMID 28655061 DOI: 10.1001/Jamaoncol.2017.1040 |
0.662 |
|
| 2016 |
Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, ... ... Wheeler CM, et al. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region. Papillomavirus Research (Amsterdam, Netherlands). 2: 61-69. PMID 29074187 DOI: 10.1016/J.Pvr.2016.03.002 |
0.679 |
|
| 2016 |
Cuzick J, Wheeler C. Need for expanded HPV genotyping for cervical screening. Papillomavirus Research. 2: 112-115. PMID 29074170 DOI: 10.1016/J.Pvr.2016.05.004 |
0.713 |
|
| 2016 |
Folschweiller N, Berlaimont V, Rachel Skinner S, Wheeler CM, Karkada N, Struyf F, Ryser M. Letter to the Editor in response to O.M. Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemporary Clinical Trials 47 (2016) 254-258. Contemporary Clinical Trials. PMID 28034686 DOI: 10.1016/J.Cct.2016.12.022 |
0.608 |
|
| 2016 |
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstetrics and Gynecology. PMID 27824767 DOI: 10.1097/Aog.0000000000001721 |
0.489 |
|
| 2016 |
Benard VB, Castle PE, Jenison SA, Hunt WC, Kim JJ, Cuzick J, Lee JH, Du R, Robertson M, Norville S, Wheeler CM. Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era. Jama Oncology. PMID 27685805 DOI: 10.1001/Jamaoncol.2016.3609 |
0.677 |
|
| 2016 |
Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Lazcano-Ponce E, Torres-Ibarra L, León-Maldonado L, Ramírez P, Rivera B, Hernández R, Franco EL, Cuzick J, Méndez-Hernández P, Salmerón J. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico. Bmc Infectious Diseases. 16: 461. PMID 27585544 DOI: 10.1186/S12879-016-1782-X |
0.719 |
|
| 2016 |
Salmerón J, Torres-Ibarra L, Bosch FX, Cuzick J, Lörincz A, Wheeler CM, Castle PE, Robles C, Lazcano-Ponce E. HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico. Salud PúBlica De MéXico. 58: 211-9. PMID 27557379 DOI: 10.21149/Spm.V58I2.7790 |
0.631 |
|
| 2016 |
McDonald YJ, Goldberg DW, Scarinci IC, Castle PE, Cuzick J, Robertson M, Wheeler CM. Health Service Accessibility and Risk in Cervical Cancer Prevention: Comparing Rural Versus Nonrural Residence in New Mexico. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association. PMID 27557124 DOI: 10.1111/Jrh.12202 |
0.435 |
|
| 2016 |
Wheeler CM, Skinner SR, Del Rosario-Raymundo MR, Garland SM, Chatterjee A, Lazcano-Ponce E, Salmerón J, McNeil S, Stapleton JT, Bouchard C, Martens MG, Money DM, Quek SC, Romanowski B, Vallejos CS, et al. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. The Lancet. Infectious Diseases. PMID 27373900 DOI: 10.1016/S1473-3099(16)30120-7 |
0.603 |
|
| 2016 |
Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM. Corrigendum to "A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry" [HumAN PatholOGY 2013;44:2542-2548]. Human Pathology. PMID 27141825 DOI: 10.1016/J.Humpath.2016.04.001 |
0.39 |
|
| 2016 |
Gravitt P, Patterson N, Stanislawski E, Colquitt E, Norville S, Cuzick J, Wheeler CM. Prevalence of Sexually Transmitted Infections and Coinfection in a Population-Based Sample of Women Attending Cervical Cancer Screening in New Mexico, United States of America Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1003 |
0.42 |
|
| 2016 |
Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, ... ... Wheeler CM, et al. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region Papillomavirus Research. 2: 61-69. DOI: 10.1016/j.pvr.2016.03.002 |
0.482 |
|
| 2015 |
Skinner SR, Wheeler CM, Romanowski B, Castellsagué X, Lazcano-Ponce E, Del Rosario-Raymundo MR, Vallejos C, Minkina G, Da Silva DP, McNeil S, Prilepskaya V, Gogotadze I, Money D, Garland SM, Romanenko V, et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. International Journal of Cancer. Journal International Du Cancer. PMID 26685704 DOI: 10.1002/Ijc.29971 |
0.678 |
|
| 2015 |
Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose VP, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, et al. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. Journal of General Internal Medicine. PMID 26658934 DOI: 10.1007/S11606-015-3552-7 |
0.327 |
|
| 2015 |
Castro FA, Koshiol J, Quint W, Wheeler CM, Gillison ML, Vaughan LM, Kleter B, van Doorn LJ, Chaturvedi AK, Hildesheim A, Schiffman M, Wang SS, Zuna RE, Walker JL, Dunn ST, et al. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. Bmc Infectious Diseases. 15: 544. PMID 26607224 DOI: 10.1186/S12879-015-1281-5 |
0.664 |
|
| 2015 |
Starling R, Nodulman JA, Kong AS, Wheeler CM, Buller DB, Woodall WG. Usability Testing of an HPV Information Website for Parents and Adolescents. Online Journal of Communication and Media Technologies. 5: 184-203. PMID 26594313 |
0.496 |
|
| 2015 |
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, Group Author NM. Risk Stratification using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-wide Surveillance Program. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26518316 DOI: 10.1158/1055-9965.Epi-15-0669 |
0.617 |
|
| 2015 |
Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Annals of Internal Medicine. 163: 589-97. PMID 26414147 DOI: 10.7326/M15-0420 |
0.416 |
|
| 2015 |
Kreimer AR, Struyf F, Hildesheim A, David MP, Wheeler CM. Fewer than three doses of HPV vaccine - Authors' reply. The Lancet. Oncology. 16: e424-5. PMID 26370346 DOI: 10.1016/S1470-2045(15)00196-5 |
0.635 |
|
| 2015 |
Pickard A, McDade SS, McFarland M, McCluggage WG, Wheeler CM, McCance DJ. HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures. Plos Pathogens. 11: e1004988. PMID 26107517 DOI: 10.1371/Journal.Ppat.1004988 |
0.604 |
|
| 2015 |
Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. The Lancet. Oncology. 16: 775-86. PMID 26071347 DOI: 10.1016/S1470-2045(15)00047-9 |
0.63 |
|
| 2015 |
Dareng EO, Ma B, Famooto AO, Akarolo-Anthony SN, Offiong RA, Olaniyan O, Dakum PS, Wheeler CM, Fadrosh D, Yang H, Gajer P, Brotman RM, Ravel J, Adebamowo CA. Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. Epidemiology and Infection. 1-15. PMID 26062721 DOI: 10.1017/S0950268815000965 |
0.589 |
|
| 2015 |
Nodulman JA, Starling R, Kong AS, Buller DB, Wheeler CM, Woodall WG. Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs. The Journal of School Health. 85: 289-98. PMID 25846308 DOI: 10.1111/Josh.12253 |
0.629 |
|
| 2015 |
Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, Naud P, Salmerón J, Chow SN, Kitchener HC, Teixeira JC, Jaisamrarn U, Limson G, Szarewski A, Romanowski B, et al. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial. Clinical and Vaccine Immunology : Cvi. 22: 361-73. PMID 25651922 DOI: 10.1128/Cvi.00591-14 |
0.724 |
|
| 2015 |
Stoler MH, Ronnett BM, Joste NE, Hunt WC, Cuzick J, Wheeler CM. The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV Status. The American Journal of Surgical Pathology. 39: 729-36. PMID 25602796 DOI: 10.1097/Pas.0000000000000381 |
0.689 |
|
| 2015 |
Struyf F, Colau B, Wheeler CM, Naud P, Garland S, Quint W, Chow SN, Salmerón J, Lehtinen M, Del Rosario-Raymundo MR, Paavonen J, Teixeira JC, Germar MJ, Peters K, Skinner SR, et al. Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA. Clinical and Vaccine Immunology : Cvi. 22: 235-44. PMID 25540273 DOI: 10.1128/Cvi.00457-14 |
0.725 |
|
| 2015 |
Cuzick J, Myers O, Hunt WC, Saslow D, Castle PE, Kinney W, Waxman A, Robertson M, Wheeler CM. Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management. International Journal of Cancer. Journal International Du Cancer. 136: 2854-63. PMID 25447979 DOI: 10.1002/Ijc.29337 |
0.624 |
|
| 2015 |
Joste NE, Ronnett BM, Hunt WC, Pearse A, Langsfeld E, Leete T, Jaramillo M, Stoler MH, Castle PE, Wheeler CM. Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 230-40. PMID 25363635 DOI: 10.1158/1055-9965.Epi-14-0775 |
0.753 |
|
| 2015 |
Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, Naud P, Salmerón J, Chow SN, Kitchener HC, Teixeira JC, Jaisamrarn U, Limson G, Szarewski A, Romanowski B, et al. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: Final event-driven analysis of the randomized, double-blind PATRICIA trial Clinical and Vaccine Immunology. 22: 361-373. DOI: 10.1128/CVI.00591-14 |
0.62 |
|
| 2015 |
Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: Combined analysis of data from the Costa Rica Vaccine and PATRICIA trials The Lancet Oncology. DOI: 10.1016/S1470-2045(15)00047-9 |
0.457 |
|
| 2014 |
Castellsagué X, Paavonen J, Jaisamrarn U, Wheeler CM, Skinner SR, Lehtinen M, Naud P, Chow SN, Del Rosario-Raymundo MR, Teixeira JC, Palmroth J, de Carvalho NS, Germar MJ, Peters K, Garland SM, et al. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial. Bmc Infectious Diseases. 14: 551. PMID 25927224 DOI: 10.1186/S12879-014-0551-Y |
0.717 |
|
| 2014 |
Yang Z, Cuzick J, Hunt WC, Wheeler CM. Concurrence of multiple human papillomavirus infections in a large US population-based cohort. American Journal of Epidemiology. 180: 1066-75. PMID 25355446 DOI: 10.1093/Aje/Kwu267 |
0.751 |
|
| 2014 |
Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, ... ... Wheeler CM, et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1997-2008. PMID 25274978 DOI: 10.1158/1055-9965.Epi-14-0410 |
0.723 |
|
| 2014 |
Starling R, Nodulman JA, Kong AS, Wheeler CM, Buller DB, Woodall WG. Beta-test Results for an HPV Information Web site: GoHealthyGirls.org - Increasing HPV Vaccine Uptake in the United States. Journal of Consumer Health On the Internet. 18: 226-237. PMID 25221442 DOI: 10.1080/15398285.2014.931771 |
0.506 |
|
| 2014 |
Dunne EF, Markowitz LE, Taylor LD, Unger ER, Wheeler CM. Human papilloma virions in the laboratory. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 61: 196-8. PMID 25088765 DOI: 10.1016/J.Jcv.2014.06.014 |
0.69 |
|
| 2014 |
Akarolo-Anthony SN, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM, Adebamowo CA. Age-specific prevalence of human papilloma virus infection among Nigerian women. Bmc Public Health. 14: 656. PMID 24972674 DOI: 10.1186/1471-2458-14-656 |
0.716 |
|
| 2014 |
Castellsagué X, Naud P, Chow SN, Wheeler CM, Germar MJ, Lehtinen M, Paavonen J, Jaisamrarn U, Garland SM, Salmerón J, Apter D, Kitchener H, Teixeira JC, Skinner SR, Limson G, et al. Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA. The Journal of Infectious Diseases. 210: 517-34. PMID 24610876 DOI: 10.1093/Infdis/Jiu139 |
0.725 |
|
| 2014 |
Castle PE, Hunt WC, Langsfeld E, Wheeler CM. Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test. Obstetrics and Gynecology. 123: 49-56. PMID 24463663 DOI: 10.1097/Aog.0000000000000013 |
0.739 |
|
| 2014 |
Kinney W, Hunt WC, Dinkelspiel H, Robertson M, Cuzick J, Wheeler CM. Cervical excisional treatment of young women: a population-based study. Gynecologic Oncology. 132: 628-35. PMID 24395062 DOI: 10.1016/J.Ygyno.2013.12.037 |
0.519 |
|
| 2014 |
Cuzick J, Myers O, Hunt WC, Robertson M, Joste NE, Castle PE, Benard VB, Wheeler CM. A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 765-73. PMID 24302677 DOI: 10.1158/1055-9965.Epi-13-0973 |
0.455 |
|
| 2014 |
Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States. International Journal of Cancer. Journal International Du Cancer. 135: 624-34. PMID 24226935 DOI: 10.1002/Ijc.28605 |
0.751 |
|
| 2014 |
Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM. No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. The Journal of Infectious Diseases. 209: 855-64. PMID 24179110 DOI: 10.1093/Infdis/Jit577 |
0.656 |
|
| 2013 |
Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, Wheeler CM, Salmerón J, Chow SN, Apter D, Teixeira JC, Skinner SR, Hedrick J, Szarewski A, Romanowski B, et al. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. Plos One. 8: e79260. PMID 24260180 DOI: 10.1371/Journal.Pone.0079260 |
0.745 |
|
| 2013 |
Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM, Adebamowo CA. HIV associated high-risk HPV infection among Nigerian women. Bmc Infectious Diseases. 13: 521. PMID 24192311 DOI: 10.1186/1471-2334-13-521 |
0.6 |
|
| 2013 |
Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM. A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry. Human Pathology. 44: 2542-8. PMID 24075599 DOI: 10.1016/J.Humpath.2013.06.015 |
0.572 |
|
| 2013 |
Famooto A, Almujtaba M, Dareng E, Akarolo-Anthony S, Ogbonna C, Offiong R, Olaniyan O, Wheeler CM, Doumatey A, Rotimi CN, Adeyemo A, Adebamowo CA. RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women. Plos One. 8: e66930. PMID 23826176 DOI: 10.1371/Journal.Pone.0066930 |
0.596 |
|
| 2013 |
Wheeler CM. The natural history of cervical human papillomavirus infections and cervical cancer: gaps in knowledge and future horizons. Obstetrics and Gynecology Clinics of North America. 40: 165-76. PMID 23732023 DOI: 10.1016/J.Ogc.2013.02.004 |
0.716 |
|
| 2013 |
de Sanjose S, Wheeler CM, Quint WG, Hunt WC, Joste NE, Alemany L, Xavier Bosch F, Myers ER, Castle PE. Age-specific occurrence of HPV16- and HPV18-related cervical cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1313-8. PMID 23632816 DOI: 10.1158/1055-9965.Epi-13-0053 |
0.747 |
|
| 2013 |
Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1095-101. PMID 23603204 DOI: 10.1158/1055-9965.Epi-12-1455 |
0.739 |
|
| 2013 |
Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM. Cervical histopathology variability among laboratories: a population-based statewide investigation. American Journal of Clinical Pathology. 139: 330-5. PMID 23429369 DOI: 10.1309/Ajcpsd3Zxjxp7Nnb |
0.603 |
|
| 2013 |
Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Pearse A, Montoya GD, Robertson M, Shearman CA, Castle PE. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. International Journal of Cancer. Journal International Du Cancer. 132: 198-207. PMID 22532127 DOI: 10.1002/Ijc.27608 |
0.747 |
|
| 2013 |
Akarolo-Anthony SN, Ogbonna CC, Famooto OA, Dareng EO, Al-Mujtaba M, Odonye G, Olaniyan O, Offiong R, Lawal I, Wheeler C, Adebamowo CA. HIV-associated high-risk HPV infection in Nigerian women. Journal of Clinical Oncology. 31: 1576-1576. DOI: 10.1200/Jco.2013.31.15_Suppl.1576 |
0.642 |
|
| 2013 |
Nodulman JA, Kong AS, Starling R, Bryan AD, Romero J, Wheeler CM, Buller DB, Woodall WG. 15. Challenges to Implementing an HPV Education and Vaccination Program in New Mexico Journal of Adolescent Health. 52: S27-S28. DOI: 10.1016/J.Jadohealth.2012.10.069 |
0.577 |
|
| 2012 |
Moscicki AB, Wheeler CM, Romanowski B, Hedrick J, Gall S, Ferris D, Poncelet S, Zahaf T, Moris P, Geeraerts B, Descamps D, Schuind A. Immune responses elicited by a fourth dose of the HPV-16/18 AS04-adjuvanted vaccine in previously vaccinated adult women. Vaccine. 31: 234-41. PMID 23063422 DOI: 10.1016/J.Vaccine.2012.09.037 |
0.66 |
|
| 2012 |
Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet. Oncology. 13: 89-99. PMID 22075171 DOI: 10.1016/S1470-2045(11)70286-8 |
0.671 |
|
| 2012 |
Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Teixeira JC, Skinner SR, Jaisamrarn U, Limson G, Romanowski B, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet. Oncology. 13: 100-10. PMID 22075170 DOI: 10.1016/S1470-2045(11)70287-X |
0.713 |
|
| 2012 |
Szarewski A, Poppe WA, Skinner SR, Wheeler CM, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Hedrick J, Jaisamrarn U, Limson G, et al. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. International Journal of Cancer. Journal International Du Cancer. 131: 106-16. PMID 21858807 DOI: 10.1002/Ijc.26362 |
0.726 |
|
| 2012 |
Castle P, Hunt WC, Wheeler C. Human Papillomavirus (HPV) Genotype Prevalence Survey in the General Population of New Mexico: The New Mexico HPV Pap Registry American Journal of Clinical Pathology. 138. DOI: 10.1093/Ajcp/138.Suppl1.025 |
0.696 |
|
| 2011 |
Castle PE, Gage JC, Wheeler CM, Schiffman M. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstetrics and Gynecology. 118: 1222-9. PMID 22105250 DOI: 10.1097/Aog.0B013E318237Caf4 |
0.651 |
|
| 2011 |
Wheeler CM. Less is more: a step in the right direction for human papillomavirus (HPV) vaccine implementation. Journal of the National Cancer Institute. 103: 1424-5. PMID 21908769 DOI: 10.1093/Jnci/Djr354 |
0.688 |
|
| 2011 |
Wheeler CM, Harvey BM, Pichichero ME, Simon MW, Combs SP, Blatter MM, Marshall GS, Catteau G, Dobbelaere K, Descamps D, Dubin G, Schuind A. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial. The Pediatric Infectious Disease Journal. 30: e225-34. PMID 21817954 DOI: 10.1097/Inf.0B013E31822D28Df |
0.465 |
|
| 2011 |
Castle PE, Gutierrez EC, Leitch SV, Maus CE, McMillian RA, Nussbaumer WA, Vaughan LM, Wheeler CM, Gravitt PE, Schiffman M. Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. Journal of Clinical Microbiology. 49: 3029-32. PMID 21632892 DOI: 10.1128/Jcm.00422-11 |
0.717 |
|
| 2011 |
Haupt RM, Wheeler CM, Brown DR, Garland SM, Ferris DG, Paavonen JA, Lehtinen MO, Steben M, Joura EA, Giacoletti KE, Radley DR, James MK, Saah AJ, Sings HL. Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. International Journal of Cancer. Journal International Du Cancer. 129: 2632-42. PMID 21491420 DOI: 10.1002/Ijc.25940 |
0.721 |
|
| 2011 |
Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Hernandez-Avila M, Brown DR, Elbasha E, Muñoz N, Paavonen J, Haupt RM, et al. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 287-96. PMID 21300618 DOI: 10.1158/1055-9965.Epi-10-0791 |
0.687 |
|
| 2011 |
Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM. Eurogin 2010 roadmap on cervical cancer prevention. International Journal of Cancer. Journal International Du Cancer. 128: 2765-74. PMID 21207409 DOI: 10.1002/Ijc.25915 |
0.709 |
|
| 2011 |
Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, et al. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. International Journal of Cancer. Journal International Du Cancer. 128: 1344-53. PMID 20949623 DOI: 10.1002/Ijc.25723 |
0.714 |
|
| 2011 |
Wheeler C, Paavonen J, Naud P, Salmeron J, Chow S, Apter D, Kitchener H, Castellsagué X, Teixeira J. Efficacy of the ASO4-adjuvanted HPV-16/18 vaccine in reduction of abnormal cytology, colposcopy referrals and cervical excision therapies: PATRICIA end-of-study results Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.042 |
0.68 |
|
| 2010 |
Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, Castle PE. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Research. 70: 8578-86. PMID 20959485 DOI: 10.1158/0008-5472.Can-10-1188 |
0.66 |
|
| 2010 |
Wheeler CM. HPV genotypes: implications for worldwide cervical cancer screening and vaccination. The Lancet. Oncology. 11: 1013-4. PMID 20952255 DOI: 10.1016/S1470-2045(10)70249-7 |
0.694 |
|
| 2010 |
Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. Bmj (Clinical Research Ed.). 341: c3493. PMID 20647284 DOI: 10.1136/Bmj.C3493 |
0.692 |
|
| 2010 |
Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1675-81. PMID 20615885 DOI: 10.1158/1055-9965.Epi-10-0251 |
0.71 |
|
| 2010 |
Gage JC, Schiffman M, Solomon D, Wheeler CM, Castle PE. Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1668-74. PMID 20615884 DOI: 10.1158/1055-9965.Epi-09-1286 |
0.714 |
|
| 2010 |
Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Brown DR, Elbasha EH, Paavonen J, Haupt RM. Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1585-94. PMID 20530494 DOI: 10.1158/1055-9965.Epi-09-1235 |
0.656 |
|
| 2010 |
Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Journal of the National Cancer Institute. 102: 325-39. PMID 20139221 DOI: 10.1093/Jnci/Djp534 |
0.744 |
|
| 2010 |
Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Impact of improved classification on the association of human papillomavirus with cervical precancer. American Journal of Epidemiology. 171: 155-63. PMID 20007673 DOI: 10.1093/Aje/Kwp390 |
0.719 |
|
| 2010 |
Wilkinson DE, Baylis SA, Padley D, Heath AB, Ferguson M, Pagliusi SR, Quint WG, Wheeler CM. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA. International Journal of Cancer. Journal International Du Cancer. 126: 2969-83. PMID 19904756 DOI: 10.1002/Ijc.25039 |
0.659 |
|
| 2010 |
Maucort-Boulch D, Plummer M, Castle PE, Demuth F, Safaeian M, Wheeler CM, Schiffman M. Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. International Journal of Cancer. Journal International Du Cancer. 126: 684-91. PMID 19609952 DOI: 10.1002/Ijc.24752 |
0.666 |
|
| 2009 |
Castle PE, Wentzensen N, Wheeler CM, Rydzak G, Schiffman M. Effect of the number of biopsies on the subsequent acquisition of new human papillomavirus infections. Obstetrics and Gynecology. 114: 1057-62. PMID 20168107 DOI: 10.1097/Aog.0B013E3181Bb5632 |
0.728 |
|
| 2009 |
Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, Somani R, Barbier S, Blatter MM, Chambers C, Ferris D, ... ... Wheeler CM, et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet (London, England). 374: 1975-85. PMID 19962185 DOI: 10.1016/S0140-6736(09)61567-1 |
0.592 |
|
| 2009 |
Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Tang GW, et al. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Human Vaccines. 5: 696-704. PMID 19855170 DOI: 10.4161/Hv.5.10.9515 |
0.702 |
|
| 2009 |
Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prevention Research (Philadelphia, Pa.). 2: 868-78. PMID 19789295 DOI: 10.1158/1940-6207.Capr-09-0031 |
0.692 |
|
| 2009 |
Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (London, England). 374: 301-14. PMID 19586656 DOI: 10.1016/S0140-6736(09)61248-4 |
0.709 |
|
| 2009 |
Franceschi S, Cuzick J, Herrero R, Dillner J, Wheeler CM. EUROGIN 2008 roadmap on cervical cancer prevention. International Journal of Cancer. Journal International Du Cancer. 125: 2246-55. PMID 19521965 DOI: 10.1002/Ijc.24634 |
0.71 |
|
| 2009 |
Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1341-9. PMID 19423515 DOI: 10.1158/1055-9965.Epi-08-1180 |
0.648 |
|
| 2009 |
Massad LS, Einstein M, Myers E, Wheeler CM, Wentzensen N, Solomon D. The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecologic Oncology. 114: 360-4. PMID 19410282 DOI: 10.1016/J.Ygyno.2009.04.005 |
0.657 |
|
| 2009 |
Castle PE, Kreimer AR, Wacholder S, Wheeler CM, Koutsky LA, Rydzak G, Buckman DW, Graubard B, Schiffman M. Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections. The Journal of Infectious Diseases. 199: 1612-20. PMID 19405865 DOI: 10.1086/598981 |
0.608 |
|
| 2009 |
Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Research. 69: 3262-6. PMID 19351830 DOI: 10.1158/0008-5472.Can-08-4192 |
0.74 |
|
| 2009 |
Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. Journal of the National Cancer Institute. 101: 475-87. PMID 19318628 DOI: 10.1093/Jnci/Djn510 |
0.746 |
|
| 2009 |
Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. The Journal of Infectious Diseases. 199: 926-35. PMID 19236279 DOI: 10.1086/597307 |
0.71 |
|
| 2009 |
Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. The Journal of Infectious Diseases. 199: 936-44. PMID 19236277 DOI: 10.1086/597309 |
0.752 |
|
| 2009 |
Xi LF, Koutsky LA, Castle PE, Wheeler CM, Galloway DA, Mao C, Ho J, Kiviat NB. Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. Journal of the National Cancer Institute. 101: 153-61. PMID 19176451 DOI: 10.1093/Jnci/Djn461 |
0.704 |
|
| 2009 |
Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstetrics and Gynecology. 113: 18-25. PMID 19104355 DOI: 10.1097/01.Ogx.0000347334.07172.51 |
0.71 |
|
| 2009 |
Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study (Cancer Epidemiology Biomarkers and Prevention (2009) 18, 1, (1341-9)) Cancer Epidemiology Biomarkers and Prevention. 18: 1943. DOI: 10.1158/1055-9965.Epi-18-6-Cor2 |
0.442 |
|
| 2008 |
Wheeler CM. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstetrics and Gynecology Clinics of North America. 35: 519-36; vii. PMID 19061814 DOI: 10.1016/J.Ogc.2008.09.006 |
0.761 |
|
| 2008 |
Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Olsson SE, et al. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine. 26: 6844-51. PMID 18930097 DOI: 10.1016/J.Vaccine.2008.09.073 |
0.701 |
|
| 2008 |
Gravitt PE, Coutlée F, Iftner T, Sellors JW, Quint WG, Wheeler CM. New technologies in cervical cancer screening. Vaccine. 26: K42-52. PMID 18847556 DOI: 10.1016/J.Vaccine.2008.05.002 |
0.382 |
|
| 2008 |
Castle PE, Cox JT, Schiffman M, Wheeler CM, Solomon D. Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology. Obstetrics and Gynecology. 112: 637-45. PMID 18757663 DOI: 10.1097/Aog.0B013E3181834637 |
0.652 |
|
| 2008 |
Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. Journal of Clinical Microbiology. 46: 2595-604. PMID 18579716 DOI: 10.1128/Jcm.00824-08 |
0.738 |
|
| 2008 |
Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1248-54. PMID 18483347 DOI: 10.1158/1055-9965.Epi-07-2904 |
0.633 |
|
| 2008 |
Castle PE, Cox JT, Jeronimo J, Solomon D, Wheeler CM, Gravitt PE, Schiffman M. An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstetrics and Gynecology. 111: 847-56. PMID 18378743 DOI: 10.1097/Aog.0B013E318168460B |
0.683 |
|
| 2008 |
Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer DL. HPV and Cervical Cancer Testing and Prevention: Knowledge, Beliefs, and Attitudes Among Hispanic Women Qualitative Health Research. 18: 584-596. PMID 18337618 DOI: 10.1177/1049732308315734 |
0.747 |
|
| 2008 |
Deshpande A, Wheeler CM, Hunt WC, Peyton CL, White PS, Valdez YE, Nolan JP. Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer. The Journal of Infectious Diseases. 197: 371-81. PMID 18248301 DOI: 10.1086/524300 |
0.683 |
|
| 2008 |
Wheeler CM, Bautista OM, Tomassini JE, Nelson M, Sattler CA, Barr E. Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines. Vaccine. 26: 686-96. PMID 18164106 DOI: 10.1016/J.Vaccine.2007.11.043 |
0.642 |
|
| 2008 |
Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. Journal of Clinical Microbiology. 46: 109-17. PMID 17989194 DOI: 10.1128/Jcm.01667-07 |
0.73 |
|
| 2007 |
Saslow D, Wheeler CM. Human papillomavirus vaccines: who will pay, who will receive, when to administer? Ethnicity & Disease. 17: S2-8-13. PMID 17684807 |
0.555 |
|
| 2007 |
Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet (London, England). 369: 2161-70. PMID 17602732 DOI: 10.1016/S0140-6736(07)60946-5 |
0.737 |
|
| 2007 |
Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 369: 1693-702. PMID 17512854 DOI: 10.1016/S0140-6736(07)60777-6 |
0.68 |
|
| 2007 |
Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. The New England Journal of Medicine. 356: 1928-43. PMID 17494926 DOI: 10.1056/Nejmoa061760 |
0.597 |
|
| 2007 |
Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. The Journal of Infectious Diseases. 195: 1582-9. PMID 17471427 DOI: 10.1086/516784 |
0.667 |
|
| 2007 |
Garland SM, Steben M, Hernandez-Avila M, Koutsky LA, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Esser MT, Vuocolo SC, Nelson M, Railkar R, Sattler C, et al. Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines. Clinical and Vaccine Immunology : Cvi. 14: 792-5. PMID 17428949 DOI: 10.1128/Cvi.00478-06 |
0.671 |
|
| 2007 |
Xi LF, Kiviat NB, Wheeler CM, Kreimer A, Ho J, Koutsky LA. Risk of cervical intraepithelial neoplasia grade 2 or 3 after loop electrosurgical excision procedure associated with human papillomavirus type 16 variants. The Journal of Infectious Diseases. 195: 1340-4. PMID 17397005 DOI: 10.1086/513441 |
0.673 |
|
| 2007 |
Wheeler CM. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nature Clinical Practice. Oncology. 4: 224-35. PMID 17392713 DOI: 10.1038/Ncponc0770 |
0.732 |
|
| 2007 |
Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, Noller KL, Wheeler CM, Ades T, Andrews KS, Doroshenk MK, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. Ca: a Cancer Journal For Clinicians. 57: 7-28. PMID 17237032 DOI: 10.3322/Canjclin.57.1.7 |
0.673 |
|
| 2007 |
Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE. Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 11-6. PMID 17220326 DOI: 10.1158/1055-9965.Epi-06-0710 |
0.729 |
|
| 2007 |
Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 4-10. PMID 17220325 DOI: 10.1158/1055-9965.Epi-06-0670 |
0.743 |
|
| 2006 |
Wheeler CM, Hunt WC, Schiffman M, Castle PE. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. The Journal of Infectious Diseases. 194: 1291-9. PMID 17041856 DOI: 10.1086/507909 |
0.731 |
|
| 2006 |
Pagliusi SR, Dillner J, Pawlita M, Quint WG, Wheeler CM, Ferguson M. Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update. Vaccine. 24: S3/193-200. PMID 16950007 DOI: 10.1016/J.Vaccine.2006.06.016 |
0.664 |
|
| 2006 |
Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutsky LA. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. Journal of the National Cancer Institute. 98: 1045-52. PMID 16882941 DOI: 10.1093/Jnci/Djj297 |
0.694 |
|
| 2006 |
Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, Brown DR, Ferenczy A, Harper DM, Koutsky LA, Kurman RJ, Lehtinen M, Malm C, Olsson SE, Ronnett BM, ... ... Wheeler CM, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 24: 5571-83. PMID 16753240 DOI: 10.1016/J.Vaccine.2006.04.068 |
0.684 |
|
| 2006 |
Kreimer AR, Guido RS, Solomon D, Schiffman M, Wacholder S, Jeronimo J, Wheeler CM, Castle PE. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 908-14. PMID 16702369 DOI: 10.1158/1055-9965.Epi-05-0845 |
0.74 |
|
| 2006 |
Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. Journal of Clinical Microbiology. 44: 1755-62. PMID 16672403 DOI: 10.1128/Jcm.44.5.1755-1762.2006 |
0.687 |
|
| 2006 |
Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (London, England). 367: 1247-55. PMID 16631880 DOI: 10.1016/S0140-6736(06)68439-0 |
0.712 |
|
| 2006 |
Quint WG, Pagliusi SR, Lelie N, de Villiers EM, Wheeler CM. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. Journal of Clinical Microbiology. 44: 571-9. PMID 16455914 DOI: 10.1128/Jcm.44.2.571-579.2006 |
0.726 |
|
| 2006 |
Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstetrics and Gynecology. 107: 18-27. PMID 16394035 DOI: 10.1097/01.Aog.0000192397.41191.Fb |
0.723 |
|
| 2006 |
Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E. Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia Obstetrical & Gynecological Survey. 61: 315-316. DOI: 10.1097/01.Ogx.0000216516.16259.9B |
0.71 |
|
| 2005 |
Schiff MA, Apple RJ, Lin P, Nelson JL, Wheeler CM, Becker TM. HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Human Immunology. 66: 1050-6. PMID 16386646 DOI: 10.1016/J.Humimm.2005.09.002 |
0.455 |
|
| 2005 |
Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears. American Journal of Clinical Pathology. 124: 722-32. PMID 16203281 DOI: 10.1309/E067X0L1U3Cy37Nw |
0.457 |
|
| 2005 |
Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. Journal of the National Cancer Institute. 97: 1066-71. PMID 16030304 DOI: 10.1093/Jnci/Dji186 |
0.709 |
|
| 2005 |
Castle PE, Walker JL, Schiffman M, Wheeler CM. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology International Journal of Cancer. 117: 1007-1012. PMID 15986443 DOI: 10.1002/Ijc.21279 |
0.676 |
|
| 2005 |
Franceschi S, Clifford GM, Schiffman M, Castle PE, Solomon D, Stoler M, Wheeler CM. Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests (multiple letters) [4] Journal of the National Cancer Institute. 97: 938-941. PMID 15956659 DOI: 10.1093/jnci/dji159 |
0.586 |
|
| 2005 |
Arias-Pulido H, Peyton CL, Torrez-Martínez N, Anderson DN, Wheeler CM. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1regions Virology. 338: 22-34. PMID 15936050 DOI: 10.1016/J.Virol.2005.04.022 |
0.694 |
|
| 2005 |
McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology Cancer Epidemiology Biomarkers and Prevention. 14: 1165-1170. PMID 15894667 DOI: 10.1158/1055-9965.Epi-04-0918 |
0.587 |
|
| 2005 |
Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. Journal of Virology. 79: 6741-50. PMID 15890912 DOI: 10.1128/Jvi.79.11.6741-6750.2005 |
0.622 |
|
| 2005 |
Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. The Lancet. Oncology. 6: 271-8. PMID 15863374 DOI: 10.1016/S1470-2045(05)70101-7 |
0.583 |
|
| 2005 |
Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. The Journal of Infectious Diseases. 191: 969-76. PMID 15717274 DOI: 10.1086/427826 |
0.542 |
|
| 2005 |
Schiffman M, Khan MJ, Solomon D, Herrero R, Wacholder S, Hildesheim A, Rodriguez AC, Bratti MC, Wheeler CM, Burk RD. A study of the impact of adding HPV types to cervical cancer screening and triage test Journal of the National Cancer Institute. 97: 147-150. PMID 15657345 DOI: 10.1093/Jnci/Dji014 |
0.713 |
|
| 2005 |
Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, Decarvalho NS, Roteli-Martins CM, Teixeira J, Blotter MM, Kom AP, Quint W, et al. Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial Obstetrical & Gynecological Survey. 60: 171-173. DOI: 10.1097/01.Ogx.0000154423.27940.68 |
0.738 |
|
| 2005 |
Schiffman M, Castle PE, Solomon D, Stoler M, Wheeler C. RESPONSE: Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests Journal of the National Cancer Institute. 97: 939-941. DOI: 10.1093/Jnci/Dji160 |
0.642 |
|
| 2004 |
Castle PE, Schiffman M, Wheeler CM. Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer American Journal of Obstetrics and Gynecology. 191: 1590-1597. PMID 15547529 DOI: 10.1016/J.Ajog.2004.05.018 |
0.578 |
|
| 2004 |
Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (London, England). 364: 1757-65. PMID 15541448 DOI: 10.1016/S0140-6736(04)17398-4 |
0.708 |
|
| 2004 |
Castle PE, Wheeler CM, Solomon D, Schiffman M, Peyton CL. Interlaboratory reliability of hybrid capture 2 American Journal of Clinical Pathology. 122: 238-245. PMID 15323141 DOI: 10.1309/ba43-hmca-j26v-wqh3 |
0.683 |
|
| 2004 |
Fife KH, Wheeler CM, Koutsky LA, Barr E, Brown DR, Schiff MA, Kiviat NB, Jansen KU, Barber H, Smith JF, Tadesse A, Giacoletti K, Smith PR, Suhr G, Johnson DA. Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women. Vaccine. 22: 2943-52. PMID 15246631 DOI: 10.1016/J.Vaccine.2003.11.058 |
0.677 |
|
| 2004 |
Brown DR, Fife KH, Wheeler CM, Koutsky LA, Lupinacci LM, Railkar R, Suhr G, Barr E, Dicello A, Li W, Smith JF, Tadesse A, Jansen KU. Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine. Vaccine. 22: 2936-42. PMID 15246630 DOI: 10.1016/J.Vaccine.2003.11.059 |
0.677 |
|
| 2004 |
Arias-Pulido H, Joste N, Wheeler CM. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype Genes Chromosomes and Cancer. 40: 277-284. PMID 15188450 DOI: 10.1002/Gcc.20048 |
0.627 |
|
| 2003 |
Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M. Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiology Biomarkers and Prevention. 12: 1038-1044. PMID 14578140 |
0.644 |
|
| 2003 |
Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. Journal of Virological Methods. 112: 23-33. PMID 12951209 DOI: 10.1016/S0166-0934(03)00186-1 |
0.719 |
|
| 2003 |
Badal V, Chuang LS, Tan EH, Badal S, Villa LL, Wheeler CM, Li BF, Bernard HU. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. Journal of Virology. 77: 6227-34. PMID 12743279 DOI: 10.1128/Jvi.77.11.6227-6234.2003 |
0.645 |
|
| 2003 |
Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous A, Drouin P, Wheeler CM, Dubuc-Lissoir J, Gauthier P, Allaire G, Vauclair R, Dipaolo JA, Gravitt P, Franco E, Coutlée F. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. American Journal of Obstetrics and Gynecology. 188: 129-34. PMID 12548206 DOI: 10.1067/Mob.2003.66 |
0.373 |
|
| 2002 |
Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. The New England Journal of Medicine. 347: 1645-51. PMID 12444178 DOI: 10.1056/Nejmoa020586 |
0.66 |
|
| 2002 |
Schiffman M, Wheeler CM, Castle PE. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities Journal of Infectious Diseases. 186: 1169-1172. PMID 12355370 DOI: 10.1086/343816 |
0.72 |
|
| 2002 |
Emeny RT, Wheeler CM, Jansen KU, Hunt WC, Fu TM, Smith JF, MacMullen S, Esser MT, Paliard X. Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine. Journal of Virology. 76: 7832-42. PMID 12097595 DOI: 10.1128/Jvi.76.15.7832-7842.2002 |
0.761 |
|
| 2002 |
Van Doorn LJ, Quint W, Kleter B, Molijn A, Colau B, Martin MT, Kravang-In, Torrez-Martinez N, Peyton CL, Wheeler CM. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF10 line probe assay Journal of Clinical Microbiology. 40: 979-983. PMID 11880426 DOI: 10.1128/Jcm.40.3.979-983.2002 |
0.725 |
|
| 2002 |
Wheeler CM. Clinical aspects and epidemiology of HPV infections Perspectives in Medical Virology. 8: 1-29. DOI: 10.1016/S0168-7069(02)08014-X |
0.746 |
|
| 2001 |
Schiff MA, Patterson RE, Baumgartner RN, Masuk M, Van Asselt-King L, Wheeler CM, Becker TM. Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women Cancer Epidemiology Biomarkers and Prevention. 10: 1219-1222. PMID 11700272 |
0.384 |
|
| 2001 |
Wang SS, Wheeler CM, Hildesheim A, Schiffman M, Herrero R, Bratti MC, Sherman ME, Alfaro M, Hutchinson ML, Morales J, Lorincz A, Burk RD, Carrington M, Erlich HA, Apple RJ. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: Results from a population-based study in Costa Rica Journal of Infectious Diseases. 184: 1310-1314. PMID 11679920 DOI: 10.1086/324209 |
0.681 |
|
| 2001 |
Brown DR, Bryan JT, Schroeder JM, Robinson TS, Fife KH, Wheeler CM, Barr E, Smith PR, Chiacchierini L, DiCello A, Jansen KU. Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: Correlation with competitive radioimmunoassay titer Journal of Infectious Diseases. 184: 1183-1186. PMID 11598842 DOI: 10.1086/323645 |
0.722 |
|
| 2001 |
Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detection in a US population Journal of Infectious Diseases. 183: 1554-1564. PMID 11343204 DOI: 10.1086/320696 |
0.705 |
|
| 2001 |
Juárez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-Glez CJ, Zamilpa-Mejía LG, García-Cisneros S, Hernández-Avila M. Human papillomavirus: A highly prevalent sexually transmitted disease agent among female sex workers from Mexico City Sexually Transmitted Diseases. 28: 125-130. PMID 11289192 DOI: 10.1097/00007435-200103000-00001 |
0.72 |
|
| 2000 |
Schiff M, Miller J, Masuk M, Van Asselt King L, Altobelli KK, Wheeler CM, Becker TM. Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women International Journal of Epidemiology. 29: 983-998. PMID 11101538 DOI: 10.1093/Ije/29.6.983 |
0.574 |
|
| 2000 |
Schiff M, Becker TM, Masuk M, van Asselt-King L, Wheeler CM, Altobelli KK, North CQ, Nahmias AJ. Risk factors for cervical intraepithelial neoplasia in Southwestern American Indian women American Journal of Epidemiology. 152: 716-726. PMID 11052549 DOI: 10.1093/Aje/152.8.716 |
0.497 |
|
| 2000 |
Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity Journal of General Virology. 81: 1975-1981. PMID 10900036 DOI: 10.1099/0022-1317-81-8-1975 |
0.512 |
|
| 2000 |
Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses Journal of Clinical Microbiology. 38: 357-361. PMID 10618116 DOI: 10.1128/Jcm.38.1.357-361.2000 |
0.684 |
|
| 2000 |
Arias H, Murty V, Martinez N, Wheeler C, Belefõ N, Martinez G, Posso H. Loss of heterozygosity at 6p21.3 and the presence of the HPV-16 E6 350G variant in cervical cancer International Journal of Gynecology & Obstetrics. 70: B150-B150. DOI: 10.1016/S0020-7292(00)83206-3 |
0.576 |
|
| 1999 |
Emeny RT, Herron JR, Xi LF, Koutsky LA, Kiviat NB, Wheeler CM. Comparison of variant-specific hybridization and single-strand conformational polymorphism methods for detection of mixed human papillomavirus type 16 variant infections. Journal of Clinical Microbiology. 37: 3627-33. PMID 10523565 DOI: 10.1128/Jcm.37.11.3627-3633.1999 |
0.825 |
|
| 1999 |
Eriksson A, Herron JR, Yamada T, Wheeler CM. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. The Journal of General Virology. 80: 595-600. PMID 10091997 DOI: 10.1099/0022-1317-80-3-595 |
0.554 |
|
| 1999 |
Hildesheim A, Hadjimichael O, Schwartz PE, Wheeler CM, Barnes W, Lowell DM, Willett J, Schiffman M. Risk factors for rapid-onset cervical cancer. American Journal of Obstetrics and Gynecology. 180: 571-7. PMID 10076130 DOI: 10.1016/S0002-9378(99)70256-5 |
0.512 |
|
| 1999 |
Peyton CL, Schiffman M, Lörincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM. Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies Journal of Clinical Microbiology. 37: 478-478. DOI: 10.1128/jcm.37.2.478-478.1999 |
0.418 |
|
| 1998 |
Peyton CL, Schiffman M, Lörincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM. Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies Journal of Clinical Microbiology. 36: 3248-3254. PMID 9774574 DOI: 10.1128/Jcm.36.11.3248-3254.1998 |
0.575 |
|
| 1998 |
Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method Journal of Clinical Microbiology. 36: 3020-3027. PMID 9738060 DOI: 10.1128/Jcm.36.10.3020-3027.1998 |
0.69 |
|
| 1998 |
Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. Genomic Variation of Human Papillomavirus Type 16 and Risk for High-Grade Cervical Intraepithelial Neoplasia Journal of Lower Genital Tract Disease. 2: 231. DOI: 10.1097/00128360-199810000-00009 |
0.462 |
|
| 1997 |
Wheeler CM. Preventive vaccines for cervical cancer Salud Publica De Mexico. 39: 283-287. PMID 9337561 DOI: 10.1590/S0036-36341997000400006 |
0.666 |
|
| 1997 |
Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia Journal of the National Cancer Institute. 89: 796-802. PMID 9182978 DOI: 10.1093/JNCI/89.11.796 |
0.738 |
|
| 1997 |
Yamada T, Manos MM, Peto J, Greer CE, Muñoz N, Bosch FX, Wheeler CM. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective Journal of Virology. 71: 2463-2472. PMID 9032384 DOI: 10.1128/Jvi.71.3.2463-2472.1997 |
0.67 |
|
| 1997 |
Wheeler CM, Yamada T, Hildesheim A, Jenison SA. Human papillomavirus type 16 sequence variants: Identification by E6 and L1 lineage-specific hybridization Journal of Clinical Microbiology. 35: 11-19. PMID 8968874 DOI: 10.1128/Jcm.35.1.11-19.1997 |
0.666 |
|
| 1997 |
Wheeler C, Greer C, Becker T, Hunt W, Anderson S, Manor M. Short-Term Fluctuations in the Detection of Cervical Human Papillomavirus DNA Journal of Lower Genital Tract Disease. 1: 97. DOI: 10.1097/00128360-199704000-00014 |
0.392 |
|
| 1997 |
Wheeler C, Greer C, Becker T, Hunt W, Anderson S, Manor M. Microcolposcopic Topographic Endocervical Assessment Before Excisional Treatment of Cervical Intraepithelial Neoplasia Journal of Lower Genital Tract Disease. 1: 96. DOI: 10.1097/00128360-199704000-00013 |
0.524 |
|
| 1996 |
Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. International Journal of Cancer. 69: 364-368. PMID 8900368 DOI: 10.1002/(Sici)1097-0215(19961021)69:5<364::Aid-Ijc2>3.0.Co;2-3 |
0.739 |
|
| 1996 |
Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA Obstetrics and Gynecology. 88: 261-268. PMID 8692513 DOI: 10.1016/0029-7844(96)00120-2 |
0.717 |
|
| 1996 |
Stewart ACM, Eriksson AM, Manos MM, Muñoz N, Bosch FX, Peto J, Wheeler CM. Intratype variation in 12 human papillomavirus types: A worldwide perspective Journal of Virology. 70: 3127-3136. PMID 8627792 DOI: 10.1128/Jvi.70.5.3127-3136.1996 |
0.739 |
|
| 1995 |
Stewart ACM, Gravitt PE, Cheng Z, Wheeler CM. Generation of entire human papillomavirus genomes by long PCR: Frequency of errors produced during amplification Genome Research. 5: 79-88. PMID 8717058 DOI: 10.1101/Gr.5.1.79 |
0.608 |
|
| 1995 |
Apple RJ, Becker TM, Wheeler CM, Erlich HA. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma Journal of the National Cancer Institute. 87: 427-436. PMID 7861462 DOI: 10.1093/Jnci/87.6.427 |
0.662 |
|
| 1995 |
Greer CE, Wheeler CM, Ladner MB, Beutner K, Coyne MY, Liang H, Langenberg A, Yen TS, Ralston R. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. Journal of Clinical Microbiology. 33: 2058-63. PMID 7559948 DOI: 10.1128/jcm.33.8.2058-2063.1995 |
0.687 |
|
| 1995 |
Yamada T, Wheeler CM, Halpern AL, Stewart ACM, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments Journal of Virology. 69: 7743-7753. PMID 7494284 DOI: 10.1128/Jvi.69.12.7743-7753.1995 |
0.488 |
|
| 1994 |
Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity Nature Genetics. 6: 157-162. PMID 8162070 DOI: 10.1038/Ng0294-157 |
0.647 |
|
| 1994 |
Becker TM, Wheeler CM, McGough NS, Parmenter CA, Jordan SW, Stidley CA, McPherson RS, Dorin MH. Sexually transmitted diseases and other risk factors for cervical dysplasia among Southwestern Hispanic and non-Hispanic white women Journal of the American Medical Association. 271: 1181-1188. PMID 8151876 DOI: 10.1001/Jama.1994.03510390051029 |
0.573 |
|
| 1994 |
Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 Journal of the National Cancer Institute. 86: 494-499. PMID 8133532 DOI: 10.1093/Jnci/86.7.494 |
0.732 |
|
| 1994 |
Manos MM, Waldman J, Zhang TY, Greer CE, Eichinger G, Schiffman MH, Wheeler CM. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. The Journal of Infectious Diseases. 170: 1096-9. PMID 7963700 DOI: 10.1093/Infdis/170.5.1096 |
0.648 |
|
| 1994 |
Peyton CL, Jansen AM, Wheeler CM, Stewart A, Peto J, Bosch FX, MuñOz N, Teyssie AR, Torroella M, Wabinga HR, Sarjadi, Ngelangel C, Manos MM. A Novel Human Papillomavirus Sequence From An International Cervical Cancer Study The Journal of Infectious Diseases. 170: 1093-1095. PMID 7963699 DOI: 10.1093/Infdis/170.5.1093 |
0.713 |
|
| 1994 |
Peyton CL, Wheeler CM. Identification of five novel human papillomavirus sequences in the new mexico triethnic population Journal of Infectious Diseases. 170: 1089-1092. PMID 7963698 DOI: 10.1093/Infdis/170.5.1089 |
0.706 |
|
| 1994 |
Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms Journal of Infectious Diseases. 170: 1077-1085. PMID 7963696 DOI: 10.1093/Infdis/170.5.1077 |
0.673 |
|
| 1994 |
Becker TM, Wheeler CM, Mcgough NS, Stidley CA, Parmenter CA, Dorin MH, Jordan SW. Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women International Journal of Epidemiology. 23: 913-922. PMID 7860171 DOI: 10.1093/Ije/23.5.913 |
0.626 |
|
| 1994 |
Apple RJ, Wheeler CM, Klitz W, Manos MM, Becker TM, Erlich HA. HLA DR-DQ disease associations with cervical carcinoma show human papillomavirus-type specificity Human Immunology. 39: 146. DOI: 10.1016/0198-8859(94)90223-2 |
0.484 |
|
| 1993 |
Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A, Manos MM. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sexually Transmitted Diseases. 20: 286-9. PMID 8235927 DOI: 10.1097/00007435-199309000-00009 |
0.607 |
|
| 1993 |
Becker TM, Wheeler CM, McPherson RS, Kratochvil A, Parmenter CA, North CQ, Miller JA. Risk factors for cervical dysplasia in southwestern American Indian women: a pilot study. Alaska Medicine. 35: 255-63. PMID 8160918 |
0.424 |
|
| 1993 |
Kirnbauer R, Wheeler C, Hubbert N, Taub J, Roden R, Lowy D, Schiller J. Human papillomavirus type 16 virus-like particles: Elisa to detect high risk HPV infection and potential for a preventive vaccine Journal of Dermatological Science. 6: 7. DOI: 10.1016/0923-1811(93)90806-Z |
0.634 |
|
| 1992 |
Becker TM, Wheeler CM, Key CR, Samet JM. Cervical cancer incidence and mortality in New Mexico's Hispanics, American Indians, and non-Hispanic whites Western Journal of Medicine. 156: 376-379. PMID 1574879 |
0.384 |
|
| 1991 |
Becker TM, Wheeler CM, McGough NS, Jordan SW, Dorin M, Miller J. Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic White women in New Mexico American Journal of Public Health. 81: 582-586. PMID 1849706 DOI: 10.2105/Ajph.81.5.582 |
0.674 |
|
| 1990 |
Manos M, Lee K, Greer C, Waldman J, Kiviat N, Holmes K, Wheeler C. Looking for human papillomavirus type 16 by PCR. The Lancet. 335: 734. PMID 1969096 DOI: 10.1016/0140-6736(90)90855-Y |
0.47 |
|
| Show low-probability matches. |